Federal award
KBR WYLE SERVICES, LLC
0133
Contract
Obligated and Ceiling
- Obligated (net)
- $5,363,659.46
- Ceiling (potential value, not spending)
- $6,698,562.00
- Current value
- $6,698,562.00
- Gross positive obligations
- $5,563,642.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0133
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 17 · Mar 25, 2010 to Jul 3, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History17
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 3, 2019 | FY2019 | 1B | C | −$7,207.85 | |
| Mar 22, 2017 | FY2017 | 1A | C | −$127,774.69 | |
| Nov 7, 2012 | FY2013 | 14 | C | $244,530.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 14, 2012 | FY2012 | 13 | C | $151,050.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 6, 2012 | FY2012 | 12 | C | $331,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 18, 2012 | FY2012 | 11 | B | −$65,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 12, 2012 | FY2012 | 10 | C | $65,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 11, 2012 | FY2012 | 9 | C | $263,145.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 16, 2012 | FY2012 | 8 | C | $655,412.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 17, 2011 | FY2012 | 7 | C | $558,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 23, 2011 | FY2011 | 6 | C | $100,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 26, 2011 | FY2011 | 5 | C | $913,725.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 15, 2011 | FY2011 | 4 | C | $317,025.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 15, 2011 | FY2011 | 3 | C | $269,509.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 13, 2010 | FY2011 | 2 | C | $530,491.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 13, 2010 | FY2010 | 1 | C | $920,755.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 25, 2010 | FY2010 | 0 | — | $244,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.